In a report released today, Sanjit Singh from Morgan Stanley maintained a Hold rating on Alteryx (AYX – Research Report), with a price target of $79.00. The company’s shares closed last Wednesday at $60.81.
According to TipRanks.com, Singh is a 4-star analyst with an average return of 7.7% and a 50.5% success rate. Singh covers the Technology sector, focusing on stocks such as SolarWinds, Sumo Logic, and Confluent.
Alteryx has an analyst consensus of Moderate Buy, with a price target consensus of $79.00.
Based on Alteryx’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $158 million and GAAP net loss of $106 million. In comparison, last year the company earned revenue of $119 million and had a GAAP net loss of $40.66 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alteryx, Inc. engages in the provision of self-service data analytics software. Its subscription-based platform allows organizations to prepare, blend, and analyze data from a multitude of sources and benefit from data-driven decisions. The company was founded by Dean A. Stoecker, Olivia Duane-Adams, and Edward P. Harding, Jr. in March 1997 and is headquartered in Irvine, CA.
Read More on AYX:
- RBC Capital Reaffirms Their Buy Rating on Surgery Partners (SGRY)
- Boise Cascade (BCC) Gets a Hold Rating from Goldman Sachs
- Sarepta Therapeutics (SRPT) Gets a Hold Rating from Morgan Stanley
- RBC Capital Believes Sarepta Therapeutics (SRPT) Still Has Room to Grow
- Zimmer Biomet Holdings (ZBH) Gets a Hold Rating from Morgan Stanley